• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】21674

【品名】1H-pyrrole

【CA登记号】109-97-7

【 分 子 式 】C4H5N

【 分 子 量 】67.09044

【元素组成】C 71.61% H 7.51% N 20.88%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(I)

The reaction between pyrrole (I) and 3,4-difluoronitrobenzene (II) afforded the N-aryl pyrrole (III). Selective reduction of the nitro group of (III) by hydrogenation over sulfided platinum on carbon gave aniline (IV), which was converted to carbamate (V) upon treatment with benzyl chloroformate. Subsequent condensation of (V) with (R)-(-)-glycidyl butyrate (VI) in the presence of lithium bis(trimethylsilyl)amide produced the chiral oxazolidinone (VII). Mesylation of the alcohol group of (VII), followed by displacement with NaN3 yielded azide (VIII). This was reduced by hydrogenation over Pt/C/S to give amine (IX), which was finally acetylated using Ac2O and pyridine.

1 Emmert, D.E.; Reischer, R.J.; Ford, C.W.; Garmon, S.A.; Zurenko, G.E.; Barbachyn, M.R.; Hutchinson, D.K.; Stelzer, L.S.; Hester, J.B.; Synthesis and antibacterial activity of azolylphenyloxazolidinones having nitrogen-bound five-membered heterocyclic rings. 38th Intersci Conf Antimicrob Agents Chemother (Sept 24 1998, San Diego) 1998, Abst F-137.
2 Hutchinson, D.K. (Pharmacia & Upjohn AB); Hetero-aromatic ring substd. phenyloxazolidinone antimicrobials. EP 0807112; JP 1998513446; US 5910504; WO 9623788 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
10101 Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene 501-53-1 C8H7ClO2 详情 详情
(I) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(II) 17013 1,2-difluoro-4-nitrobenzene; 3,4-Difluoronitrobenzene 369-34-6 C6H3F2NO2 详情 详情
(III) 29412 1-(2-fluoro-4-nitrophenyl)-1H-pyrrole C10H7FN2O2 详情 详情
(IV) 29413 3-fluoro-4-(1H-pyrrol-1-yl)phenylamine3-fluoro-4-(1H-pyrrol-1-yl)aniline C10H9FN2 详情 详情
(V) 29414 benzyl 3-fluoro-4-(1H-pyrrol-1-yl)phenylcarbamate C18H15FN2O2 详情 详情
(VI) 18385 (2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate 60456-26-0 C7H12O3 详情 详情
(VII) 29415 (5R)-3-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one C14H13FN2O3 详情 详情
(VIII) 29416 (5R)-5-(azidomethyl)-3-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1,3-oxazolidin-2-one C14H12FN5O2 详情 详情
(IX) 29417 (5S)-5-(aminomethyl)-3-[3-fluoro-4-(1H-pyrrol-1-yl)phenyl]-1,3-oxazolidin-2-one C14H14FN3O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

Condensation of N-(tert-butoxycarbonyl)phenylalanine methyl ester (I) with pyrrolyl magnesium bromide (generated from pyrrole (II) and MeMgBr) furnished ketone (III). The N-Boc group of (III) was deprotected with HCl in dioxan to yield aminoketone (IV), which was then condensed with the succinate building block (V) in DMF to afford succinamide (VI). Further deprotection of the tert-butyl ester of (VI) by treatment with trifluoroacetic acid provided carboxylic acid (VII), which was coupled with O-tert-butyldimethylsilyl hydroxylamine (VIII) in the presence of EDC and HOBt to yield, after desilylation, the target hydroxamic acid.

1 Sheppard, G.S.; Florjancic, A.S.; Giesler, J.R.; Xu, L.; Guo, Y.; Davidsen, S.K.; Marcotte, P.A.; Elmore, I.; Albert, D.H.; Terrance, J.M.; Bouska, J.J.; Goodfellow, C.L.; Morgan, D.W.; Summers, J.B.; Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitors. Bioorg Med Chem Lett 1998, 8, 22, 3251.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21673 methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropanoate C15H21NO4 详情 详情
(II) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(III) 21675 tert-butyl (1S)-1-benzyl-2-oxo-2-(1H-pyrrol-2-yl)ethylcarbamate C18H22N2O3 详情 详情
(IV) 21676 (2S)-2-amino-3-phenyl-1-(1H-pyrrol-2-yl)-1-propanone hydrochloride C13H15ClN2O 详情 详情
(V) 21641 1-(tert-butyl) 4-(2,3,4,5,6-pentafluorophenyl) (2S,3R)-2-allyl-3-isobutylbutanedioate C21H25F5O4 详情 详情
(VI) 21678 tert-butyl (2S)-2-[(1R)-1-([[(1S)-1-benzyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]amino]carbonyl)-3-methylbutyl]-4-pentenoate C28H38N2O4 详情 详情
(VII) 21679 (2S)-2-[(1R)-1-([[(1S)-1-benzyl-2-oxo-2-(1H-pyrrol-2-yl)ethyl]amino]carbonyl)-3-methylbutyl]-4-pentenoic acid C24H30N2O4 详情 详情
(VIII) 21644 (Aminooxy)(tert-butyl)dimethylsilane; O-[tert-Butyl(dimethyl)silyl]hydroxylamine 41879-39-4 C6H17NOSi 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

Lithiation of 3-fluoropyridine (I) followed by formylation with methyl formate afforded aldehyde (II). Porphyrin (IV) was then prepared by condensation of aldehyde (II) with pyrrole (III) in refluxing propionic acid. Methylation of (IV) using methyl p-toluenesulfonate then gave the title pyridinium tosylate salt.

1 Shin, J.-H.; Namgoong, S.K.; Kim, H.-S.; Moon, S.C.; Jeong, B.H.; Lee, B.S.; Yu, B.S.; Lee, J.-S.; Synthesis of tetrakis(multifluoro-4-pyridyl)porphin derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem Lett 2000, 10, 13, 1435.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46855 3-fluoropyridine 372-47-4 C5H4FN 详情 详情
(II) 46856 3-fluoroisonicotinaldehyde C6H4FNO 详情 详情
(III) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(IV) 46857 2,7,12,17-tetrakis(3-fluoro-4-pyridinyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1(3,6).1(8,11).1(13,16)]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene C40H22F4N8 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

Tetrakis-(2-pyridyl)porphyrin (III) was prepared by condensation between pyridine-2-carboxaldehyde (I) and pyrrole (II) in refluxing propionic acid. Metallation of porphyrin (III) was performed with MnCl2, which spontaneously underwent oxidation, yielding the Mn3+ complex (IV). Subsequent N-alkylation of the pyridine rings with ethyl iodide produced the corresponding pyridinium iodide salt, which was transformed to the analogous chloride by treatment with tetrabutylammonium chloride (1). In an alternative procedure, initial quaternization of the pyridine rings of porphyrin (III) with ethyl p-toluenesulfonate afforded (V), which was further metallated with MnCl2 to give the title compound.

2 Kachadourian, R.; et al.; Synthesis and superoxide dismuting activities of partially (1-4) beta-chlorinated derivatives of manganese (III) meso-tetrakis (N-ethylpyridinium-2-yl)porphyrin. Inorg Chem 1999, 38, 2, 391.
3 Bloodsworth, A.; et al.; Manganese-porphyrin reactions with lipid and lipoproteins. Free Radical Biol Med 2000, 28, 7, 1017.
4 Batinic-Haberle, I.; Fridovich, I. (Duke University); Substd. porphyrins. EP 1045851; JP 2001521939; WO 9923097 .
1 Batinié-Haberle, I.; et al.; Relationships among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of magnase(III) and iron(III) water-soluble porphyrins. Inorg Chem 1999, 38, 18, 4011.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 25173 2-pyridinecarbaldehyde 1121-60-4 C6H5NO 详情 详情
(II) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(III) 51699 2,7,12,17-tetra(2-pyridinyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1(3,6).1(8,11).1(13,16)]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene C40H26N8 详情 详情
(IV) 51700   C40H24MnN8 详情 详情
(V) 51701 1-ethyl-2-[7,12,17-tris(1-ethyl-2-pyridiniumyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1(3,6).1(8,11).1(13,16)]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-2-yl]pyridinium C48H46N8 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

The tetraimidazolyl porphyrin (III) was prepared by reaction between 1-ethylimidazole-2-carboxaldehyde (I) and pyrrole (II) in refluxing propionic acid. Quaternization of the imidazole groups of (III) with iodoethane furnished the tetrakis-imidazolium iodide salt (IV). After complexation of porphyrin (IV) with manganese(III) acetate, its precipitation as the hexafluorophosphate salt followed by anion exchange with tetrabutylammonium chloride, furnished the title chelate pentachloride salt.

1 Trova, M.P.; Kitchen, D.B.; Crapo, J.D.; Gauuan, P.J.F.; Day, B.J. (National Jewish Medical and Research Center); Substd. porphyrins. EP 1155019; JP 2002535332; WO 0043395 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 58657 1-ethyl-1H-imidazole-2-carbaldehyde C6H8N2O 详情 详情
(II) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(III) 58658 2,7,12,17-tetrakis(1-ethyl-1H-imidazol-2-yl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene C40H38N12 详情 详情
(IV) 58659 1,3-diethyl-2-[7,12,17-tris(1,3-diethyl-1H-imidazol-3-ium-2-yl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-2-yl]-1H-imidazol-3-ium tetraiodide C48H58I4N12 详情 详情

合成路线6

该中间体在本合成路线中的序号:(VII)

Dilithiation of thiophene (I) employing an excess of BuLi in the presence of TMEDA produced the intermediate 2,5-dilithiothiophene (II). Addition of 4-fluorobenzaldehyde (III) to the organolithium compound (II) afforded the bis-carbinol adduct (IV). Alternatively, addition of benzaldehyde (V) to (II) provided adduct (VI). Boron trifluoride-catalyzed condensation of pyrrole (VII) with diol (IV) yielded the bis(alpha-pyrrolylbenzyl)thiophene (VIII). The dithiaporphyrin derivative (IX) was then obtained by condensation between (VIII) and (VI) in the presence of boron trifluoride. Finally, aromatic sulfonation of (IX) with hot sulfuric acid, followed by neutralization with NaOH furnished the title disulfonate disodium salt.

1 Hilmey, D.G.; et al.; Water-soluble, core-modified porphyrins as novel longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity. J Med Chem 2002, 45, 2, 449.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 13297 Thiophene 110-02-1 C4H4S 详情 详情
(II) 54835   C4H2Li2S 详情 详情
(III) 12337 4-fluorobenzaldehyde 459-57-4 C7H5FO 详情 详情
(IV) 54836 (4-fluorophenyl){5-[(4-fluorophenyl)(hydroxy)methyl]-2-thienyl}methanol C18H14F2O2S 详情 详情
(V) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(VI) 54837 {5-[hydroxy(phenyl)methyl]-2-thienyl}(phenyl)methanol C18H16O2S 详情 详情
(VII) 21674 1H-pyrrole 109-97-7 C4H5N 详情 详情
(VIII) 54838 2-((4-fluorophenyl){5-[(4-fluorophenyl)(1H-pyrrol-2-yl)methyl]-2-thienyl}methyl)-1H-pyrrole C26H20F2N2S 详情 详情
(IX) 54839 7,12-bis(4-fluorophenyl)-2,17-diphenyl-21,23-dithia-22,24-diazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3(24),4,6,8,10,12,14,16(22),17,19-undecaene C44H26F2N2S2 详情 详情
Extended Information